SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Buy and Sell Signals, and Other Market Perspectives -- Ignore unavailable to you. Want to Upgrade?


To: codfish23 who wrote (144895)5/5/2020 4:04:03 PM
From: GROUND ZERO™  Read Replies (2) | Respond to of 219495
 
Maybe some selling early tomorrow is in order...

GZ



To: codfish23 who wrote (144895)5/5/2020 4:39:30 PM
From: Winfastorlose4 Recommendations

Recommended By
Clam digger
codfish23
Hawkmoon
Katelew

  Read Replies (2) | Respond to of 219495
 
I learned about all of that many years ago as I followed the approval progress of the first class anti-viral drug Ribavirin. It's not just whether or not there is money to be made. It is also (and this is the real problem) who is going to be allowed to make the money. I had this explained to me in great detail by a top oncologist at the NIH one day in a two hour conversation.

Ribavirin for example got nowhere in the attempt to use it for Hep C until ICN Pharmacueticals, which owned the drug, took Schering Plough as a partner. All of a sudden, no problema anymore.

Our system is crooked. It always has been. Whose palms are going to get greased and who ends up with the enchilada?

The FDA approval panel that gave the chemical sweetener Aspartame (Nutrasweet) the green light all went to work for GD Searle after the deal was done. This was in spite of lab tests which showed tumors in mice that ate it. . Searle just cut out the tumors from the mice and declared the mice tumor free"

Monsanto later bought Searle, so that alone should tell everyone to never eat the stuff.

HCQ/Z-Pack/Zinc combo treatments would not allow Big Pharma to make much money. So there is a major campaign afoot to discredit HCQ even though it is probably a part of the best treatment in the world for Covid-19

One rule of science never changes: follow the money

Almost all science as we know it is not pure. There are multiple biases, intentional and unintentional, in almost any trial. When money is involved (isn't it always?), these are amplified